124 related articles for article (PubMed ID: 38525814)
41. MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer.
Ma S; Wei H; Wang C; Han J; Chen X; Li Y
Cell Mol Biol Lett; 2021 Dec; 26(1):52. PubMed ID: 34895159
[TBL] [Abstract][Full Text] [Related]
42. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
43. Silencing of Long Non-coding RNA LINC01106 Represses Malignant Behaviors of Gastric Cancer Cells by Targeting miR-34a-5p/MYCN Axis.
Hong S; Li Q; Yang Y; Jing D; Zhu F
Mol Biotechnol; 2022 Feb; 64(2):144-155. PubMed ID: 34550549
[TBL] [Abstract][Full Text] [Related]
44. circGFRA1 affects the sensitivity of triple-negative breast cancer cells to paclitaxel via the miR-361-5p/TLR4 pathway.
Zheng SR; Huang QD; Zheng ZH; Zhang ZT; Guo GL
J Biochem; 2021 Jul; 169(5):601-611. PubMed ID: 33481008
[TBL] [Abstract][Full Text] [Related]
45. Resveratrol protects BV2 mouse microglial cells against LPS-induced inflammatory injury by altering the miR-146a-5p/TRAF6/NF-κB axis.
Ge YT; Zhong AQ; Xu GF; Lu Y
Immunopharmacol Immunotoxicol; 2019 Oct; 41(5):549-557. PubMed ID: 31530042
[No Abstract] [Full Text] [Related]
46. Genomic Index of Sensitivity to Chemotherapy for Triple Negative Breast Cancer.
Sameer C A; Shah M; Nandy D; Gupta R
Asian Pac J Cancer Prev; 2023 Jun; 24(6):2043-2053. PubMed ID: 37378935
[TBL] [Abstract][Full Text] [Related]
47. miR-589-5p Inhibits Cell Proliferation by Targeting Histone Deacetylase 3 in Triple Negative Breast Cancer.
Rahbari R; Rahimi K; Rasmi Y; Khadem-Ansari MH; Abdi M
Arch Med Res; 2022 Jul; 53(5):483-491. PubMed ID: 35840467
[TBL] [Abstract][Full Text] [Related]
48. Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness.
Darbeheshti F; Kadkhoda S; Keshavarz-Fathi M; Razi S; Bahramy A; Mansoori Y; Rezaei N
BMC Cancer; 2022 Jun; 22(1):668. PubMed ID: 35715772
[TBL] [Abstract][Full Text] [Related]
49. The regulatory effect of 6-TG on lncRNA-miRNA-mRNA ceRNA network in triple-negative breast cancer cell line.
Zhang D; An X; Yu H; Li Z
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33470407
[TBL] [Abstract][Full Text] [Related]
50. PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer.
Song W; Tang L; Xu Y; Xu J; Zhang W; Xie H; Wang S; Guan X
Sci Rep; 2017 Feb; 7():42319. PubMed ID: 28176879
[TBL] [Abstract][Full Text] [Related]
51. Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.
Furuya K; Sasaki A; Tsunoda Y; Tsuji M; Udaka Y; Oyamada H; Tsuchiya H; Oguchi K
Hum Cell; 2016 Apr; 29(2):76-82. PubMed ID: 26573286
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
53. MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib.
Jonas K; Prinz F; Ferracin M; Krajina K; Pasculli B; Deutsch A; Madl T; Rinner B; Slaby O; Klec C; Pichler M
Breast Cancer Res; 2023 Oct; 25(1):119. PubMed ID: 37803350
[TBL] [Abstract][Full Text] [Related]
54. Ursolic Acid Enhances Cytotoxicity of Doxorubicin-Resistant Triple-Negative Breast Cancer Cells via
Lu Q; Chen W; Ji Y; Liu Y; Xue X
Cancer Biother Radiopharm; 2022 Oct; 37(8):673-683. PubMed ID: 33493421
[No Abstract] [Full Text] [Related]
55. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
Chen LL; Zhang ZJ; Yi ZB; Li JJ
Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
[TBL] [Abstract][Full Text] [Related]
56. miR-1207-5p regulates the sensitivity of triple-negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression.
Hou X; Niu Z; Liu L; Guo Q; Li H; Yang X; Zhang X
Oncol Lett; 2019 Jan; 17(1):990-998. PubMed ID: 30655858
[TBL] [Abstract][Full Text] [Related]
57. In silico analysis of the association of hsa-miR-16 expression and cell survival in MDA-MB-231 breast cancer cells subjected to photodynamic therapy.
Cupido-Sánchez MG; Herrera-González NE; Mendoza CCB; Hernández MLM; Ramón-Gallegos E
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102106. PubMed ID: 33217568
[TBL] [Abstract][Full Text] [Related]
58. Exosomal-microRNA transcriptome profiling of Parental and CSC-like MDA-MB-231 cells in response to cisplatin treatment.
Koh MZ; Ho WY; Yeap SK; Ali NM; Yong CY; Boo L; Alitheen NB
Pathol Res Pract; 2022 May; 233():153854. PubMed ID: 35398617
[TBL] [Abstract][Full Text] [Related]
59. MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3.
Bai X; Han G; Liu Y; Jiang H; He Q
Biomed Pharmacother; 2018 Jul; 103():1482-1489. PubMed ID: 29864933
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-146a-5p attenuates neuropathic pain via suppressing TRAF6 signaling in the spinal cord.
Lu Y; Cao DL; Jiang BC; Yang T; Gao YJ
Brain Behav Immun; 2015 Oct; 49():119-29. PubMed ID: 25957028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
